- A Patient with Beta-Propeller Protein-Associated Neurodegeneration: Treatment with Iron Chelation Therapy
-
Lim SY, Tan AH, Ahmad-Annuar A, Schneider , Bee PC, Lim JL, Ramli N, Idris MI
- KMID: 2413381
- J Mov Disord.
- 2018 May;11(2):89-92.
- doi: 10.14802/jmd.17082
We present a case of beta-propeller protein-associated neurodegeneration, a form of neurodegeneration with brain iron accumulation. The patient harbored a novel mutation in the WDR45 gene. A detailed video and... -
- CITED
-
- Close
- SHARE
-
- Close
- Oromandibular Dystonia: Demographics and Clinical Data from 240 Patients
-
Slaim L, Cohen M, Klap P, Vidailhet , Perrin A, Brasnu D, Ayache D, Mailly M
- KMID: 2413378
- J Mov Disord.
- 2018 May;11(2):78-81.
- doi: 10.14802/jmd.17065
OBJECTIVE: To report demographic data from a large cohort of patients with oromandibular dystonia (OMD). METHODS: This is a retrospective review of patients with OMD referred to our institution between 1989... -
- CITED
-
- Close
- SHARE
-
- Close
- Transcranial Direct Current Stimulation Combined with Action Observation and Electromyographic Biofeedback Training in a Patient with Writer's Cramp
-
Okada Y, Shibamoto , Osumi Y, Asano C, Takeuchi R, Nabeshima , Morioka S, Shomoto K
- KMID: 2413379
- J Mov Disord.
- 2018 May;11(2):82-86.
- doi: 10.14802/jmd.18007
We present a 47-year-old right-handed woman with a 15-year history of writer's cramp who was provided with six sessions of cathodal transcranial direct current stimulation (tDCS) combined with observation of... -
- CITED
-
- Close
- SHARE
-
- Close
- Purposeless Groaning in Parkinson's Disease
-
Lim SY, Tan AH, Lim JL, Ahmad-Annuar A
- KMID: 2413380
- J Mov Disord.
- 2018 May;11(2):87-88.
- doi: 10.14802/jmd.18004
Purposeless groaning has been reported in advanced progressive supranuclear palsy. We present a case of purposeless groaning occurring as a primary complaint in a patient with advanced Parkinson's disease. Purposeless... -
- CITED
-
- Close
- SHARE
-
- Close
- Prospective Characterization of Cognitive Function in Typical and ‘Brainstem Predominant'Progressive Supranuclear Palsy Phenotypes
-
Lee YE, Williams D, Anderson J
- KMID: 2413377
- J Mov Disord.
- 2018 May;11(2):72-77.
- doi: 10.14802/jmd.17067
OBJECTIVE: Clinicopathological studies over the last decade have broadened the clinical spectrum of progressive supranuclear palsy (PSP) to include several distinct clinical syndromes. We examined the cognitive profiles of patients... -
- CITED
-
- Close
- SHARE
-
- Close
- Parkinson's Disease in Sub-Saharan Africa: A Review of Epidemiology, Genetics and Access to Care
-
Williams U, Bandmann O, Walker R
- KMID: 2413375
- J Mov Disord.
- 2018 May;11(2):53-64.
- doi: 10.14802/jmd.17028
A low prevalence of Parkinson's disease (PD) has been reported in the Sub-Saharan Africa (SSA) region. The genetic causes and clinical features of PD in this region have been poorly... -
- CITED
-
- Close
- SHARE
-
- Close
- Amantadine and the Risk of Dyskinesia in Patients with Early Parkinson's Disease: An Open-Label, Pragmatic Trial
-
Kim A, Kim YE, Yun JY, Kim HJ, Yang HJ, Lee WW, Shin CW, Park H, Jung YJ, Kim A, Kim Y, Jang M, Jeon B
- KMID: 2413376
- J Mov Disord.
- 2018 May;11(2):65-71.
- doi: 10.14802/jmd.18005
OBJECTIVE: We examined whether amantadine can prevent the development of dyskinesia. METHODS: Patients with drug-naïve Parkinson's disease (PD), younger than 70 years of age and in the early stage of PD... -
- CITED
-
- Close
- SHARE
-
- Close
